Perkins Adelene Q
- SEC CIK
- 0001375124
No open-market purchases or sales filed in the past year.
Current role at each company
- BRKR Bruker CorpDirectoras of Feb 18, 2026
- INFI Infinity Pharmaceuticals, Inc.Directoras of Sep 12, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Perkins Adelene Q as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
INFI Infinity Pharmaceuticals, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2023 (view filing)6:20 PM ET | Sep 12 | Same day | Perkins Adelene QDirector | SSale | −410.2K | $0.07 | −$28.7K | −25.9%1.18M after | 10b5-1 |